200 related articles for article (PubMed ID: 28514279)
1. Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
Rasmussen TA; McMahon J; Chang JJ; Symons J; Roche M; Dantanarayana A; Okoye A; Hiener B; Palmer S; Lee WS; Kent SJ; Van Der Weyden C; Prince HM; Cameron PU; Lewin SR
AIDS; 2017 Aug; 31(13):1839-1845. PubMed ID: 28514279
[TBL] [Abstract][Full Text] [Related]
2. HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
Costiniuk CT; Salahuddin S; Farnos O; Olivenstein R; Pagliuzza A; Orlova M; Schurr E; De Castro C; Bourbeau J; Routy JP; Ancuta P; Chomont N; Jenabian MA
AIDS; 2018 Oct; 32(16):2279-2289. PubMed ID: 30102653
[TBL] [Abstract][Full Text] [Related]
3. Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.
Khoury G; Anderson JL; Fromentin R; Hartogenesis W; Smith MZ; Bacchetti P; Hecht FM; Chomont N; Cameron PU; Deeks SG; Lewin SR
AIDS; 2016 Jun; 30(10):1511-20. PubMed ID: 26807971
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
5. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
Lee E; von Stockenstrom S; Morcilla V; Odevall L; Hiener B; Shao W; Hartogensis W; Bacchetti P; Milush J; Liegler T; Sinclair E; Hatano H; Hoh R; Somsouk M; Hunt P; Boritz E; Douek D; Fromentin R; Chomont N; Deeks SG; Hecht FM; Palmer S
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723024
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure.
Hey-Nguyen WJ; Bailey M; Xu Y; Suzuki K; Van Bockel D; Finlayson R; Leigh Brown A; Carr A; Cooper DA; Kelleher AD; Koelsch KK; Zaunders JJ
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):112-120. PubMed ID: 30511878
[TBL] [Abstract][Full Text] [Related]
7. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy.
Gosselin A; Wiche Salinas TR; Planas D; Wacleche VS; Zhang Y; Fromentin R; Chomont N; Cohen ÉA; Shacklett B; Mehraj V; Ghali MP; Routy JP; Ancuta P
AIDS; 2017 Jan; 31(1):35-48. PubMed ID: 27835617
[TBL] [Abstract][Full Text] [Related]
8. HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy.
Logerot S; Rancez M; Charmeteau-de Muylder B; Figueiredo-Morgado S; Rozlan S; Tambussi G; Beq S; Couëdel-Courteille A; Cheynier R
AIDS; 2018 Mar; 32(6):715-720. PubMed ID: 29369157
[TBL] [Abstract][Full Text] [Related]
9. Single TCR-Vβ2 evaluation discloses the circulating T cell clone in Sezary syndrome: one family fits all!
Scala E; Abeni D; Pomponi D; Russo N; Russo G; Narducci MG
Arch Dermatol Res; 2015 Aug; 307(6):487-93. PubMed ID: 25733488
[TBL] [Abstract][Full Text] [Related]
10. Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.
Anderson JL; Khoury G; Fromentin R; Solomon A; Chomont N; Sinclair E; Milush JM; Hartogensis W; Bacchetti P; Roche M; Tumpach C; Gartner M; Pitman MC; Epling CL; Hoh R; Hecht FM; Somsouk M; Cameron PU; Deeks SG; Lewin SR
J Infect Dis; 2020 Feb; 221(5):744-755. PubMed ID: 31796951
[TBL] [Abstract][Full Text] [Related]
11. CD32
Noto A; Procopio FA; Banga R; Suffiotti M; Corpataux JM; Cavassini M; Riva A; Fenwick C; Gottardo R; Perreau M; Pantaleo G
J Virol; 2018 Oct; 92(20):. PubMed ID: 29976671
[TBL] [Abstract][Full Text] [Related]
12. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
13. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations.
Granjo E; Lima M; Lopes JM; Cunha N; Teixeira Mdos A; Santos F; Candeias J; Resende C; Santos AH; Balanzategui A; Orfão A; Matutes E
Br J Haematol; 2002 Dec; 119(3):629-33. PubMed ID: 12437636
[TBL] [Abstract][Full Text] [Related]
14. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
16. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence.
Yukl SA; Shergill AK; Ho T; Killian M; Girling V; Epling L; Li P; Wong LK; Crouch P; Deeks SG; Havlir DV; McQuaid K; Sinclair E; Wong JK
J Infect Dis; 2013 Oct; 208(8):1212-20. PubMed ID: 23852128
[TBL] [Abstract][Full Text] [Related]
17. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.
El-Diwany R; Breitwieser FP; Soliman M; Skaist AM; Srikrishna G; Blankson JN; Ray SC; Wheelan SJ; Thomas DL; Balagopal A
AIDS; 2017 Jun; 31(10):1405-1414. PubMed ID: 28358734
[TBL] [Abstract][Full Text] [Related]
18. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.
Ananworanich J; Puthanakit T; Suntarattiwong P; Chokephaibulkit K; Kerr SJ; Fromentin R; Bakeman W; Intasan J; Mahanontharit A; Sirivichayakul S; Chomont N;
AIDS; 2014 Apr; 28(7):1015-20. PubMed ID: 24384692
[TBL] [Abstract][Full Text] [Related]
19. Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing.
Gantner P; Barnig C; Partisani M; Lee GQ; Beck-Wirth G; Faller JP; Martinot M; Mosheni-Zadeh M; Cheneau C; Batard ML; Fischer P; Fuchs A; Uring-Lambert B; Bahram S; Rey D; Fafi-Kremer S
AIDS; 2018 Apr; 32(7):921-926. PubMed ID: 29424775
[TBL] [Abstract][Full Text] [Related]
20. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
